These include known Mendelian cardiomyopathy risk genes such as <i>FLNC</i> and <i>ACTN2</i>, and novel regulatory candidates like <i>CAMK2D</i>, <i>LMF1</i>, <i>MYOZ1</i>, <i>SKI</i>, <i>SYNPO2L</i>, and <i>TKT</i>. This evidence concerns the gene MYOZ1 and cardiomyopathy.